The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Distinct neural mechanisms for the prosocial and rewarding properties of MDMA
Open accessPublished version of a preprint
Abstract
MDMA, which has both therapeutic and abuse potential, engages a brain region–specific serotonergic pathway to produce its prosocial effect.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In mice, systemic administration of a prosocial dose of MDMA enhanced sociability in the three-chamber assay, an effect that was mimicked by direct infusion of MDMA into the NAc, prevented by pharmacological inhibition of the 5-HT transporter (SERT) or its genetic deletion, and blocked by direct infusion into the NAc of a 5-HT1b receptor antagonist [51].”
From Neural circuits regulating prosocial behaviors (2023) · cites this paper as [51]
In the citing paper
“In mice, systemic administration of a prosocial dose of MDMA enhanced sociability in the three-chamber assay, an effect that was mimicked by direct infusion of MDMA into the NAc, prevented by pharmacological inhibition of the 5-HT transporter (SERT) or its genetic deletion, and blocked by direct infusion into the NAc of a 5-HT1b receptor antagonist [51].”
From Neural circuits regulating prosocial behaviors (2023) · cites this paper as [51]
In the citing paper
“In mice, systemic administration of a prosocial dose of MDMA enhanced sociability in the three-chamber assay, an effect that was mimicked by direct infusion of MDMA into the NAc, prevented by pharmacological inhibition of the 5-HT transporter (SERT) or its genetic deletion, and blocked by direct infusion into the NAc of a 5-HT1b receptor antagonist [51].”
From Neural circuits regulating prosocial behaviors (2023) · cites this paper as [51]
In the citing paper
“In mice, systemic administration of a prosocial dose of MDMA enhanced sociability in the three-chamber assay, an effect that was mimicked by direct infusion of MDMA into the NAc, prevented by pharmacological inhibition of the 5-HT transporter (SERT) or its genetic deletion, and blocked by direct infusion into the NAc of a 5-HT1b receptor antagonist [51].”
From Neural circuits regulating prosocial behaviors (2023) · cites this paper as [51]
In the citing paper
“Furthermore, administration of methamphetamine, a potent DA releaser, did not enhance sociability [51].”
From Neural circuits regulating prosocial behaviors (2023) · cites this paper as [51]
In the citing paper
“This simple form of 5-HT1b receptor-triggered synaptic plasticity was subsequently found to be generated by bath application of OXT or MDMA [41,51], results consistent with the 5-HT releasing properties of these agents.”
From Neural circuits regulating prosocial behaviors (2023) · cites this paper as [51]
In the citing paper
“In contrast, the actions of MDMA on the DA transporter (DAT) were not required for this prosocial effect, as prior administration of a DAT inhibitor did not influence MDMA's effects in the three-chamber assay.”
From Neural circuits regulating prosocial behaviors (2023) · cites this paper as [51]
In the citing paper
“Because of its abuse potential and potential toxicity [51,177], it is unlikely that MDMA itself can ever be used as a daily treatment for sociability deficits.”
From Neural circuits regulating prosocial behaviors (2023) · cites this paper as [51]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Koob, G. F., & Volkow, N. D. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2009.110 · Cited by 5,340
Moy, S. S., Nadler, J. J., Perez, A., Barbaro, R. P., Johns, J. M., Magnuson, T. R., Piven, J., & Crawley, J. N. (2004) · Genes, Brain and Behavior · doi:10.1111/j.1601-1848.2004.00076.x · Cited by 1,522 · cited 1×
“Social approach testing was performed similar to previously described methods (17).”
MethodThe Pharmacology and Clinical Pharmacology of 3,4-Methylenedioxymethamphetamine (MDMA, “Ecstasy”)
Green, A. R., Mechan, A. O., Elliott, J. M., O’Shea, E., & Colado, M. I. (2003) · Pharmacological Reviews · doi:10.1124/pr.55.3.3 · Cited by 1,272
Social reward requires coordinated activity of nucleus accumbens oxytocin and serotonin
Dölen, G., Darvishzadeh, A., Huang, K. W., & Malenka, R. C. (2013) · Nature · doi:10.1038/nature12518 · Cited by 1,161
Self-citationDrug-evoked synaptic plasticity in addiction: from molecular changes to circuit remodeling
Lüscher, C., & Malenka, R. C. (2011) · Neuron · doi:10.1016/j.neuron.2011.01.017 · Cited by 1,105
Self-citationCircuit architecture of VTA dopamine neurons revealed by systematic input-output mapping
Beier, K. T., Steinberg, E. E., DeLoach, K. E., Xie, S., Miyamichi, K., Schwarz, L., Gao, X. J., Kremer, E. J., Malenka, R. C., & Luo, L. (2015) · Cell · doi:10.1016/j.cell.2015.07.015 · Cited by 1,068
Self-citationGong, S., Doughty, M., Harbaugh, C. R., Cummins, A., Hatten, M. E., Heintz, N., & Gerfen, C. R. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.2707-07.2007 · Cited by 977
Gating of social reward by oxytocin in the ventral tegmental area
Hung, L. W., Neuner, S., Polepalli, J. S., Beier, K. T., Wright, M., Walsh, J. J., Lewis, E. M., Luo, L., Deisseroth, K., Dölen, G., et al. (2017) · Science · doi:10.1126/science.aan4994 · Cited by 578
Self-citationRudnick, G., & Wall, S. C. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.5.1817 · Cited by 535
Griebel, G., Belzung, C., Perrault, G., & Sanger, D. J. (2000) · Psychopharmacology · doi:10.1007/s002130050038 · Cited by 420
Subjective Reports of the Effects of MDMA in a Clinical Setting
Greer, G., & Tolbert, R. (1986) · Journal of Psychoactive Drugs · doi:10.1080/02791072.1986.10472364 · Cited by 413
Anhedonia requires MC4R-mediated synaptic adaptations in nucleus accumbens
Lim, B. K., Huang, K. W., Grueter, B. A., Rothwell, P. E., & Malenka, R. C. (2012) · Nature · doi:10.1038/nature11160 · Cited by 368
Self-citationThe neural mechanisms and circuitry of the pair bond
Walum, H., & Young, L. J. (2018) · Nature Reviews Neuroscience · doi:10.1038/s41583-018-0072-6 · Cited by 353
Oxytocin-dependent reopening of a social reward learning critical period with MDMA
Nardou, R., Lewis, E. M., Rothhaas, R., Xu, R., Yang, A., Boyden, E., & Dölen, G. (2019) · Nature · doi:10.1038/s41586-019-1075-9 · Cited by 334
Danforth, A. L., Grob, C. S., Struble, C., Feduccia, A. A., Walker, N., Jerome, L., Yazar-Klosinski, B., & Emerson, A. (2018) · Psychopharmacology · doi:10.1007/s00213-018-5010-9 · Cited by 280 · cited 1×
“Despite the potential negative consequences of MDMA ingestion, because of its profound prosocial effects, MDMA is being evaluated to determine its efficacy in the treatment of posttraumatic stress disorder and autism spectrum disorders (4, 5).”
BackgroundDecreased motivation during chronic pain requires long-term depression in the nucleus accumbens
Schwartz, N., Temkin, P., Jurado, S., Lim, B. K., Heifets, B. D., Polepalli, J. S., & Malenka, R. C. (2014) · Science · doi:10.1126/science.1253994 · Cited by 278
Self-citationA conditional knockout mouse line of the oxytocin receptor
Lee, H.-J., Caldwell, H. K., Macbeth, A. H., Tolu, S. G., & Young, W. S. (2008) · Endocrinology · doi:10.1210/en.2007-1710 · Cited by 269
5-HT release in nucleus accumbens rescues social deficits in mouse autism model
Walsh, J. J., Christoffel, D. J., Heifets, B. D., Ben-Dor, G. A., Selimbeyoglu, A., Hung, L. W., Deisseroth, K., & Malenka, R. C. (2018) · Nature · doi:10.1038/s41586-018-0416-4 · Cited by 256
Self-citationGudelsky, G. A., & Nash, J. F. (1996) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1996.66010243.x · Cited by 252
Liechti, M. E., & Vollenweider, F. X. (2001) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.348 · Cited by 236
Chronic tolerance to recreational MDMA (3,4-methylenedioxymethamphetamine) or Ecstasy
Parrott, A. C. (2005) · Journal of Psychopharmacology · doi:10.1177/0269881105048900 · Cited by 231
Shen, H., Hagino, Y., Kobayashi, H., Shinohara-Tanaka, K., Ikeda, K., Yamamoto, H., Yamamoto, T., Lesch, K., Murphy, D. L., Hall, F. S., et al. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300476 · Cited by 204
Therapeutic and adverse actions of serotonin transporter substrates
Rothman, R. B., & Baumann, M. H. (2002) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(02)00234-6 · Cited by 181
Do initial responses to drugs predict future use or abuse?
de Wit, H., & Phillips, T. J. (2012) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2012.04.005 · Cited by 172
Kamilar-Britt, P., & Bedi, G. (2015) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2015.08.016 · Cited by 163
Drug-induced fibrotic valvular heart disease
Bhattacharyya, S., Schapira, A. H. V., Mikhailidis, D. P., & Davar, J. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60252-x · Cited by 144
3,4-Methylenedioxymethamphetamine facilitates fear extinction learning
Young, M. B., Andero, R., Ressler, K. J., & Howell, L. L. (2015) · Translational Psychiatry · doi:10.1038/tp.2015.138 · Cited by 141
Deciphering the molecular mechanism responsible for GCaMP6m's Ca2+-dependent change in fluorescence
Barnett, L. M., Hughes, T. E., & Drobizhev, M. A. (2017) · PLoS ONE · doi:10.1371/journal.pone.0170934 · Cited by 128
Nash, J. F., & Brodkin, J. D. (1991) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)20405-0 · Cited by 125
Serotonin Induces Long-Term Depression at Corticostriatal Synapses
Mathur, B. N., Capik, N. A., Alvarez, V. A., & Lovinger, D. M. (2011) · The Journal of Neuroscience · doi:10.1523/jneurosci.6250-10.2011 · Cited by 114
Identification of a Dopamine Transporter Ligand That Blocks the Stimulant Effects of Cocaine
Desai, R. I., Kopajtic, T. A., Koffarnus, M. N., Newman, A. H., & Katz, J. L. (2005) · Journal of Neuroscience · doi:10.1523/jneurosci.4778-04.2005 · Cited by 112
Trigo, J. M., Renoir, T., Lanfumey, L., Hamon, M., Lesch, K., Robledo, P., & Maldonado, R. J. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.11.005 · Cited by 91
Brennan, K. A., Carati, C., Lea, R. A., Fitzmaurice, P. S., & Schenk, S. (2009) · Behavioural Pharmacology · doi:10.1097/fbp.0b013e328333a28d · Cited by 88
Progress and promise for the MDMA drug development program
Feduccia, A. A., Holland, J. A., & Mithoefer, M. C. (2017) · Psychopharmacology · doi:10.1007/s00213-017-4779-2 · Cited by 82
A comparison of fenfluramine and amphetamine in man
Griffith, J. D., Nutt, J. G., & Jasinski, D. R. (1975) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt1975185part1563 · Cited by 76
Chen, X., Ye, R., Gargus, J. J., Blakely, R., Dobrenis, K., & Sze, J. Y. (2015) · Cell Reports · doi:10.1016/j.celrep.2014.12.033 · Cited by 67
Self-citationReview of Fenfluramine in the Treatment of the Developmental Disabilities
Aman, M. G., & KERN, R. A. (1989) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-198907000-00014 · Cited by 61
Hagino, Y., Takamatsu, Y., Yamamoto, H., Iwamura, T., Murphy, D. L., Uhl, G. R., Sora, I., & Ikeda, K. (2011) · Current Neuropharmacology · doi:10.2174/157015911795017254 · Cited by 60
Nelson, A. B., Hang, G. B., Grueter, B. A., Pascoli, V., Lüscher, C., Malenka, R. C., & Kreitzer, A. C. (2012) · Journal of Neuroscience · doi:10.1523/jneurosci.0224-12.2012 · Cited by 56
Self-citationOakly, A., Brox, B. W., Schenk, S., & Ellenbroek, B. A. (2013) · Molecular Psychiatry · doi:10.1038/mp.2013.75 · Cited by 53
Vidal‐Infer, A., Roger-Sánchez, C., Daza‐Losada, M., Aguilar, M. A., Miñarro, J., & Rodríguez‐Arias, M. (2012) · PLoS ONE · doi:10.1371/journal.pone.0043107 · Cited by 47
Effects of MDMA on the Human Nervous System
McCann, U. D., & Ricaurte, G. A. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-418679-8.00015-0 · Cited by 11
Flagged first, then by citations
Research works printed but not linked: 1
- S. Garattini R. Samanin Central Mechanisms of Anorectic Drugs (Monographs of the Mario Negri Institute for Pharmacological Research Raven Press 1978).
Cited by
Sorted by citations
Gregorio, D. D., Aguilar‐Valles, A., Preller, K. H., Heifets, B. D., Hibicke, M., Mitchell, J., & Gobbi, G. (2020) · Journal of Neuroscience · doi:10.1523/jneurosci.1659-20.2020 · Cited by 279
Self-citationPsychedelics in Psychiatry: Neuroplastic, Immunomodulatory, and Neurotransmitter Mechanisms
Inserra, A., De Gregorio, D., & Gobbi, G. (2021) · Pharmacological Reviews · doi:10.1124/pharmrev.120.000056 · Cited by 232
Yao, Y., Guo, D., Lu, T., Liu, F.-L., Huang, S., Diao, M.-Q., Li, S., Zhang, X.-J., Kosten, T. R., Shi, J., et al. (2024) · Psychiatry Research · doi:10.1016/j.psychres.2024.115886 · Cited by 159
De Gregorio, D., Popic, J., Enns, J. P., Inserra, A., Skalecka, A., Markopoulos, A., Posa, L., Lopez-Canul, M., He, Q., Lafferty, C. K., et al. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2020705118 · Cited by 139
5-HT modulation of a medial septal circuit tunes social memory stability
Wu, X., Morishita, W., Beier, K. T., Heifets, B. D., & Malenka, R. C. (2021) · Nature · doi:10.1038/s41586-021-03956-8 · Cited by 116
Self-citation
Metadata
- Authors
- Heifets, B. D., Salgado, J. S., Taylor, M. D., Hoerbelt, P., Cardozo Pinto, D. F., Steinberg, E. E., Walsh, J. J., Sze, J. Y., & Malenka, R. C.
- Affiliations
- Stanford Medicine (US)
- Stanford University (US)
- Nancy Pritzker Laboratory, Department of Psychiatry and Behavioral Sciences, Stanford University, Stanford, CA 94305, USA.
- Albert Einstein College of Medicine (US)
- Corresponding author
- Malenka, Robert C.
- ORCID
- Venue
- Science Translational Medicine
- Published
- 2019-12-11
- Volume
- 11
- Issue
- 522
- ISSN
- 1946-6234 (ISSN-L)
- 1946-6242
- PMC
- PMC7123941
- OpenAlex
- W2994786945
- Cited by
- 120
- References
- 42
- Citations by year
- 2026: 12 · 2025: 25 · 2024: 25 · 2023: 12 · 2022: 17 · 2021: 18 · 2020: 10
- FWCI
- 13.14
- Type
- journal article
- Language
- en
- Open access
- green
- doi.org
- Licence
- cc-by-nc-nd
- Locations
- Science Translational Medicine (publishedVersion)
- bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institute of Mental Health (MH110610, MH115668, MG105839)
- National Institute on Drug Abuse (DA042012)
- Topics
- Social Sciences › Psychology › Clinical Psychology › Psychedelics and Drug Studies
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Keywords
- MDMA, ecstasy, prosocial behavior, reward, addiction, abuse liability, serotonin release, fenfluramine, neural pathways, treatment development
- MeSH terms
- Animals, Brain, Dopamine, Female, Male, Mice, Inbred C57BL, Nucleus Accumbens, Receptors, Serotonin, Reward, Social Behavior, Receptors, Oxytocin, N-Methyl-3,4-methylenedioxyamphetamine, Dopamine Plasma Membrane Transport Proteins, Serotonin Plasma Membrane Transport Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
